BIO-TECHNE (TECH) Net Income towards Common Stockholders: 2009-2025
Historic Net Income towards Common Stockholders for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $38.2 million.
- BIO-TECHNE's Net Income towards Common Stockholders rose 13.65% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year decrease of 75.73%. This contributed to the annual value of $22.2 million for FY2025, which is 82.61% down from last year.
- According to the latest figures from Q3 2025, BIO-TECHNE's Net Income towards Common Stockholders is $38.2 million, which was up 155.48% from -$68.8 million recorded in Q2 2025.
- Over the past 5 years, BIO-TECHNE's Net Income towards Common Stockholders peaked at $89.7 million during Q3 2022, and registered a low of -$68.8 million during Q2 2025.
- Over the past 3 years, BIO-TECHNE's median Net Income towards Common Stockholders value was $34.9 million (recorded in 2024), while the average stood at $27.7 million.
- In the last 5 years, BIO-TECHNE's Net Income towards Common Stockholders skyrocketed by 563.12% in 2022 and then slumped by 16,219.44% in 2025.
- Over the past 5 years, BIO-TECHNE's Net Income towards Common Stockholders (Quarterly) stood at $72.1 million in 2021, then plummeted by 30.61% to $50.0 million in 2022, then tumbled by 45.08% to $27.5 million in 2023, then grew by 27.03% to $34.9 million in 2024, then grew by 13.65% to $38.2 million in 2025.
- Its Net Income towards Common Stockholders was $38.2 million in Q3 2025, compared to -$68.8 million in Q2 2025 and $22.6 million in Q1 2025.